Dont Race Out To Buy Cementos Bio Bio S.A. Just Because Its Going Ex-Dividend - Simply Wall St
| CEMENTOS | CLP 1,400 100.00 7.69% |
About 55% of Cementos Bio's investors are presently thinking to get in. The analysis of current outlook of investing in Cementos Bio B suggests that some traders are interested regarding Cementos Bio's prospects. Cementos Bio's investing sentiment overview a quick insight into current market opportunities from investing in Cementos Bio B. Many technical investors use Cementos Bio B stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Cementos |
Dont Race Out To Buy Cementos Bio Bio S.A. Just Because Its Going Ex-Dividend Simply Wall St
Read at news.google.com
 |
Cementos Bio Fundamental Analysis
We analyze Cementos Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cementos Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cementos Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Cementos Bio is rated fifth in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Cementos Bio B Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cementos Bio stock to make a market-neutral strategy. Peer analysis of Cementos Bio could also be used in its relative valuation, which is a method of valuing Cementos Bio by comparing valuation metrics with similar companies.
Peers
Cementos Bio Related Equities
| CEMENTOS | Cementos Bio | 7.69 | ||||
| PARAUCO | Parq Arauco | 1.30 | ||||
| SMSAAM | Sociedad Matriz | 1.15 | ||||
| ENELGXCH | Enel Generacin | 0.25 | ||||
| ENTEL | Empresa Nacional | 0.86 | ||||
| AGUAS-A | Aguas Andinas | 0.94 |
Other Information on Investing in Cementos Stock
Cementos Bio financial ratios help investors to determine whether Cementos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cementos with respect to the benefits of owning Cementos Bio security.